BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire
· Advanced oncology pipeline in mid- and late-stage with plans to have ten or more potentially registrational..
· Advanced oncology pipeline in mid- and late-stage with plans to have ten or more potentially registrational..
*MAINZ, **Germany**, December 12, 2023* *(GLOBE NEWSWIRE)* – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will..
Commitments focus on advancing equitable access to artificial intelligence (AI) and vaccines, and catalyzing innovations that..